The differentiated Lapiplasty procedure is rewarding Treace Medical handsomely with top-line growth. It is capturing share of an under-penetrated instrumental procedures market. Added to that, the ...
PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
Treace Medical Concepts continues to present with attractive economic characteristics. TMCI has penetrated 5.8% of the $5bn US bunion surgery market, with management revising FY'23 revenue guidance to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback